Furthermore, TIM-3 has been observed on tumor cells, where it modulates the expansion of myeloid-derived suppressor cells (MDSCs), leading to the subsequent suppression of T cell function and a resultant attenuation of immune reactivity [43]. Here, HAVCR2 is linked to neoplasm.